心血管疾患および脳血管疾患とアスピリン潰瘍再発の評価

基本情報

NCT ID: NCT01051388
ステータス: 完了
試験のフェーズ: 第3相
試験タイプ: 介入
目標被験者数: 280
治験依頼者名: Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan

概要

The aim of this study is to evaluate the efficacy of proton pump inhibitor (PPI), comparing to the mucosal defensive drug, in the prevention of the recurrence of gastric and/or duodenal ulcers during 12 weeks observation in patients receiving low-dose aspirin for vascular protection.

対象疾患

Cardio-cerebrovascular Disease

介入

Low-dose PPI (Rabeprazole sodium)(DRUG)

High-dose PPI (Rabeprazole sodium)(DRUG)

Non-PPI (Gefarnate)(DRUG)

依頼者（Sponsor）

Gastro-intestinal Medical Care Research Center(UNKNOWN)

Translational Research Center For Medical Innovation, Kobe, Hyogo, Japan(OTHER)

実施施設 (1)

神戸元町呼吸器内科・アレルギークリニック

Kobe, Hyōgo, Japan